PMID- 25825864 OWN - NLM STAT- MEDLINE DCOM- 20160413 LR - 20211203 IS - 1549-4918 (Electronic) IS - 1066-5099 (Linking) VI - 33 IP - 7 DP - 2015 Jul TI - Novel Pathway for Hypoxia-Induced Proliferation and Migration in Human Mesenchymal Stem Cells: Involvement of HIF-1alpha, FASN, and mTORC1. PG - 2182-95 LID - 10.1002/stem.2020 [doi] AB - The control of stem cells by oxygen signaling is an important way to improve various stem cell physiological functions and metabolic nutrient alteration. Lipid metabolism alteration via hypoxia is thought to be a key factor in controlling stem cell fate and function. However, the interaction between hypoxia and the metabolic and functional changes to stem cells is incompletely described. This study aimed to identify hypoxia-inducible lipid metabolic enzymes that can regulate umbilical cord blood (UCB)-derived human mesenchymal stem cell (hMSC) proliferation and migration and to demonstrate the signaling pathway that controls functional change in UCB-hMSCs. Our results indicate that hypoxia treatment stimulates UCB-hMSC proliferation, and expression of two lipogenic enzymes: fatty acid synthase (FASN) and stearoyl-CoA desaturase-1 (SCD1). FASN but not SCD1 is a key enzyme for regulation of UCB-hMSC proliferation and migration. Hypoxia-induced FASN expression was controlled by the hypoxia-inducible factor-1 alpha (HIF-1alpha)/SCAP/SREBP1 pathway. Mammalian target of rapamycin (mTOR) was phosphorylated by hypoxia, whereas inhibition of FASN by cerulenin suppressed hypoxia-induced mTOR phosphorylation as well as UCB-hMSC proliferation and migration. RAPTOR small interfering RNA transfection significantly inhibited hypoxia-induced proliferation and migration. Hypoxia-induced mTOR also regulated CDK2, CDK4, cyclin D1, cyclin E, and F-actin expression as well as that of c-myc, p-cofilin, profilin, and Rho GTPase. Taken together, the results suggest that mTORC1 mainly regulates UCB-hMSC proliferation and migration under hypoxia conditions via control of cell cycle and F-actin organization modulating factors. In conclusion, the HIF-1alpha/FASN/mTORC1 axis is a key pathway linking hypoxia-induced lipid metabolism with proliferation and migration in UCB-hMSCs. Stem Cells 2015;33:2182-2195. CI - (c) 2015 AlphaMed Press. FAU - Lee, Hyun Jik AU - Lee HJ AD - BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Korea. FAU - Ryu, Jung Min AU - Ryu JM AD - Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, Seoul National University, Seoul, Korea. FAU - Jung, Young Hyun AU - Jung YH AD - BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Korea. FAU - Oh, Sang Yub AU - Oh SY AD - BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Korea. FAU - Lee, Sei-Jung AU - Lee SJ AD - BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Korea. FAU - Han, Ho Jae AU - Han HJ AD - BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Korea. AD - Department of Veterinary Physiology, College of Veterinary Medicine, Research Institute for Veterinary Science, Seoul National University, Seoul, Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150511 PL - England TA - Stem Cells JT - Stem cells (Dayton, Ohio) JID - 9304532 RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - EC 2.3.1.85 (FASN protein, human) RN - EC 2.3.1.85 (Fatty Acid Synthase, Type I) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Cell Differentiation MH - Cell Hypoxia MH - Cell Movement MH - Cell Proliferation MH - Fatty Acid Synthase, Type I/*metabolism MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism MH - Mesenchymal Stem Cells/cytology/*metabolism MH - Signal Transduction MH - TOR Serine-Threonine Kinases/*metabolism OTO - NOTNLM OT - Cell migration OT - Cell proliferation OT - Fatty acid synthase OT - Hypoxia OT - Hypoxia-inducible factor 1 OT - Mammalian target of rapamycin EDAT- 2015/04/01 06:00 MHDA- 2016/04/14 06:00 CRDT- 2015/04/01 06:00 PHST- 2014/08/31 00:00 [received] PHST- 2015/02/28 00:00 [accepted] PHST- 2015/04/01 06:00 [entrez] PHST- 2015/04/01 06:00 [pubmed] PHST- 2016/04/14 06:00 [medline] AID - 10.1002/stem.2020 [doi] PST - ppublish SO - Stem Cells. 2015 Jul;33(7):2182-95. doi: 10.1002/stem.2020. Epub 2015 May 11.